Leukemia Research
Volume 27, Issue 1 , Pages 35-44, January 2003

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia

Departments of Medicine, Biostatistics and Epidemiology, Pharmacology, and Pathology of University Hospitals of Cleveland, Ireland Cancer Center, Case Western Reserve University, Louis Stokes Veterans Affairs Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA

Received 23 January 2002; accepted 30 April 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(02)00079-6

Leukemia Research
Volume 27, Issue 1 , Pages 35-44, January 2003

Article Tools

* Image Usage & Resolution